Mesenchymal stem cell injections for knee OA demonstrate potential benefit .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2016;4(9):14 Int Orthop. 2015 Dec;39(12):2363-727 studies (6 RCTs and 1 CCT) that included a total of 314 patients with knee osteoarthritis (OA) were included in this meta-analysis and systematic review. The purpose of this review was to elucidate the efficacy of mesenchymal stem cell (MSC) injections in the treatment of knee OA by evaluating its effect on pain and function outcomes. While the findings of this study demonstrated potential efficacy for MSC injections for pain reduction and functional improvement that warrant further investigation, these findings were observed in a subgroup of higher quality studies or were associated with significant heterogeneity due to varying follow-up periods, doses of MSC and differing control groups. The low quality of evidence within the included trials limits the ability to draw conclusive results.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!